Cargando…
Early Combination Therapy of Ketamine and Midazolam in Patients with Refractory Status Epilepticus in Hemodynamic Unstable State
The use of anesthetics is inevitable to suppress seizure activity in refractory status epilepticus (RSE). Hypotension, which is a critical side effect observed when treating RSE using a higher dosage of anesthetics that enhance γ-aminobutyric acid (GABA) activity, often requires vasopressor agents....
Autores principales: | Choi, Jung-Won, Shin, Jung-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Epilepsy Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767219/ https://www.ncbi.nlm.nih.gov/pubmed/35087725 http://dx.doi.org/10.14581/jer.21023 |
Ejemplares similares
-
Midazolam, Ketamine, and Propofol: While We Slept, Others Worked on Anesthetizing Infusions for Refractory Status Epilepticus
por: Vossler, David G.
Publicado: (2023) -
(S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study
por: Höfler, Julia, et al.
Publicado: (2016) -
Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus
por: Zeiler, F. A.
Publicado: (2015) -
Recurrent Metabolic Acidosis during High-dose Midazolam Therapy for Refractory Status Epilepticus
por: Singh, Shalendra, et al.
Publicado: (2018) -
A Comparative Study of Midazolam and Target-Controlled Propofol Infusion in the Treatment of Refractory Status Epilepticus
por: Masapu, Dheeraj, et al.
Publicado: (2018)